Zhiwei Zhou

1.4k total citations
53 papers, 997 citations indexed

About

Zhiwei Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Zhiwei Zhou has authored 53 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 10 papers in Gastroenterology. Recurrent topics in Zhiwei Zhou's work include Gastric Cancer Management and Outcomes (14 papers), Gastrointestinal Tumor Research and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Zhiwei Zhou is often cited by papers focused on Gastric Cancer Management and Outcomes (14 papers), Gastrointestinal Tumor Research and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Zhiwei Zhou collaborates with scholars based in China, United States and Ethiopia. Zhiwei Zhou's co-authors include Toshimitsu Hamasaki, Fuminobu Sugai, Saburo Sakoda, Masashi Goto, Yoichi Yamamoto, Hisae Sumi, Katsuyuki Miyaguchi, Jing‐Ping Yun, Zhizhong Z. Pan and Zhen Lü and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhiwei Zhou

48 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiwei Zhou China	17	398	289	288	170	152	53	997
Yiyan Lei China	20	318 0.8×	434 1.5×	203 0.7×	91 0.5×	173 1.1×	70	1.0k
Francisco Bautista Spain	18	247 0.6×	329 1.1×	163 0.6×	291 1.7×	75 0.5×	74	1.1k
Zhiyong He China	19	408 1.0×	403 1.4×	337 1.2×	64 0.4×	184 1.2×	48	1.2k
Serge Milin France	20	147 0.4×	336 1.2×	157 0.5×	84 0.5×	216 1.4×	44	963
Şahsine Tolunay Türkiye	18	226 0.6×	310 1.1×	146 0.5×	105 0.6×	111 0.7×	77	870
Hiroyuki Takeda Japan	24	323 0.8×	729 2.5×	184 0.6×	68 0.4×	86 0.6×	60	1.5k
Michael J. Cavnar United States	17	502 1.3×	216 0.7×	326 1.1×	74 0.4×	248 1.6×	52	1.2k
Julie A. Mund United States	15	114 0.3×	335 1.2×	164 0.6×	118 0.7×	107 0.7×	30	688
Rosario Gil‐Benso Spain	19	146 0.4×	330 1.1×	204 0.7×	104 0.6×	87 0.6×	45	867
Tatsuo Sawada Japan	16	144 0.4×	246 0.9×	120 0.4×	121 0.7×	119 0.8×	56	719

Countries citing papers authored by Zhiwei Zhou

Since Specialization

Citations

This map shows the geographic impact of Zhiwei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Zhou more than expected).

Fields of papers citing papers by Zhiwei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiwei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Zhou. The network helps show where Zhiwei Zhou may publish in the future.

Co-authorship network of co-authors of Zhiwei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiwei Zhou. A scholar is included among the top collaborators of Zhiwei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiwei Zhou. Zhiwei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Xiaofang, et al.. (2025). Uropathogen profiles and their antimicrobial resistance patterns in patients: a three-year retrospective study in Sichuan region. Frontiers in Public Health. 13. 1493980–1493980. 1 indexed citations

Wang, Wei, Weicai Huang, Fang Cheng, et al.. (2025). Multimodal radiopathomics approach for predictions of prognosis and immunotherapy response in patients with gastric cancer: a multicohort retrospective study. International Journal of Surgery. 111(11). 7606–7621.

Nie, Run‐Cong, Ya Ding, Shuqiang Yuan, et al.. (2024). Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4083–4083. 1 indexed citations

Qiu, Haibo, Zhiwei Zhou, Ye Zhou, et al.. (2024). Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and paraganglioma.. Journal of Clinical Oncology. 42(16_suppl). 11502–11502. 9 indexed citations

Zhou, Zhiwei, Liang-Wei Chen, Shujuan Cao, et al.. (2024). A novel arabinogalactan extracted from Epiphyllum oxypetalum (DC.) Haw improves the immunity and gut microbiota in cyclophosphamide‐induced immunosuppressed mice. SHILAP Revista de lepidopterología. 5(5). 1 indexed citations

Zhou, Zhiwei, et al.. (2023). Risk factors and dynamic nomogram for unfavorable prognosis of Marchiafava–Bignami disease. Annals of Clinical and Translational Neurology. 10(11). 2013–2024. 2 indexed citations

Han, Haibo, Zhiwei Zhou, Shijie Wang, et al.. (2023). Machine learning‐based establishment and validation of age‐related patterns for predicting prognosis in non‐small cell lung cancer within the context of the tumor microenvironment. IUBMB Life. 75(11). 941–956.

Zhao, Jiawei, Eunice E. Lee, Zhiwei Zhou, et al.. (2023). GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. Journal of Clinical Investigation. 133(21). 30 indexed citations

Zhou, Jie, Run‐Cong Nie, Yixin Yin, et al.. (2022). Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy. Frontiers in Cell and Developmental Biology. 10. 906759–906759. 7 indexed citations

10.

Ding, Chao, Xu Lin, Guoqiang Wang, et al.. (2021). Comparison of a Tumor-Ratio–Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer. Frontiers in Oncology. 11. 595421–595421. 13 indexed citations

11.

Nie, Run‐Cong, Yun Wang, Jie Zhou, et al.. (2021). Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis. Frontiers in Oncology. 11. 538174–538174. 19 indexed citations

12.

Li, Qing, Zhiwei Zhou, Lu Jia, et al.. (2021). PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer. Molecular Therapy. 30(2). 621–631. 23 indexed citations

13.

Li, Ziyu, Yinkui Wang, Wei Wang, et al.. (2020). <p>A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy</p>. Cancer Management and Research. Volume 12. 2047–2055. 11 indexed citations

14.

Peng, Hong, Zhiwei Zhou, Yu Guo, et al.. (2019). Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma. EBioMedicine. 46. 105–118. 17 indexed citations

15.

Wang, Wei, Xingyu Feng, Yu Zhang, et al.. (2017). Clinicopathological characteristics and prognostic factors of rectal neuroendocrine neoplasms. Zhonghua putong waike zazhi. 32(10). 828–831. 1 indexed citations

16.

Yu, Shitong, Zhiwei Zhou, Qian Cai, et al.. (2017). Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma. OncoTargets and Therapy. Volume 10. 879–884. 23 indexed citations

17.

Nie, Run‐Cong, Shuqiang Yuan, Shi Chen, et al.. (2016). Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination. Chinese Journal of Cancer Research. 28(6). 570–578. 20 indexed citations

18.

Sun, Xiao, Pengfei Xu, Haibo Qiu, et al.. (2016). Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer. OncoTargets and Therapy. 9. 949–949. 9 indexed citations

19.

Zhou, Shu-Feng, et al.. (2015). A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis. Drug Design Development and Therapy. 9. 1063–1063. 11 indexed citations

20.

Sugai, Fuminobu, Yoichi Yamamoto, Katsuyuki Miyaguchi, et al.. (2004). Benefit of valproic acid in suppressing disease progression of ALS model mice. European Journal of Neuroscience. 20(11). 3179–3183. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact